20 articles
Expert reviews rank fisetin and quercetin as top senolytics, with spermidine and resveratrol as supporting players in longevity supplement stacks.
Expert reviews compare leading senolytic and NAD+ supplement brands on ingredients, evidence quality, and value.
A product review breaks down the evidence tiers for four popular longevity supplements and rates the best commercial stacks.
A Cochrane meta-analysis of 8 RCTs finds most pharmacological treatments fail to improve ataxia scores, though upper limb dexterity may benefit.
A Cochrane review of 21 RCTs finds remote pharmacist care may improve adherence and lower blood pressure in NCD patients.
A new review reframes magnesium as a master regulator of mitochondrial energy, metabolic disease, and biological aging.
A Cochrane meta-analysis of 17 RCTs finds amyloid-targeting antibodies offer minimal cognitive gains while significantly raising ARIA risk.
New review reveals how senescent cells both prevent and promote cancer, opening therapeutic opportunities.
A rigorous product review reveals major quality gaps in NAD+ supplements and what dosing evidence actually supports.
A 2026 comparative review of leading NAD+ supplements reveals NR has stronger human data, while NMN marketing often outpaces clinical proof.
New expert reviews compare NMN and NR head-to-head, ranking top products by purity, absorption, and clinical evidence.
A comparative review of NMN and NR supplements weighs tissue targeting, clinical evidence, and top-rated products for NAD+ optimization.
A candid breakdown of top NAD+ booster brands reveals strong biomarker data but slim evidence for real longevity outcomes.
Expert reviews compare NMN and NR head-to-head. NMN edges out for muscle and sleep benefits; NR leads for neuroprotection.
A head-to-head comparison of NMN and NR supplements reveals distinct benefit profiles — and major quality gaps across popular brands.
A Cochrane meta-analysis of 11 RCTs finds very low-certainty evidence that liver support systems neither reduce mortality nor improve key outcomes in ALF.
Both NMN and NR raise NAD+ levels in humans, but clinical proof of anti-aging benefits is still lacking — and product quality varies widely.
A new review links adult cholestasis to pediatric genetic syndromes, opening doors to targeted therapies including novel bile acid transport inhibitors.
Expert reviews confirm NR and NMN raise blood NAD+, but longevity proof remains elusive and product quality varies widely.
Expert reviews compare leading NMN and NR supplements on clinical evidence, purity, and value — with key caveats on what the science can and cannot yet prove.
